InsiderDB

Rep. Josh Gottheimer bought Arcutis Biotherapeutics (ARQT)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Apr 17, 2023

Transaction
Bought
Amount
$1K–$15K
Owner
Joint
Traded
Apr 17, 2023
Disclosed
May 19, 2023
Days to disclose
32
Asset type
Stock
As filed
Arcutis Biotherapeutics, Inc. - Common stock
Industry
Biotechnology · Healthcare

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in ARQT

Company context for ARQT

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ARQTLobbying report·Lobbying disclosures

    ARQT: third_quarter 2026 lobbying report

    Issues related to tariffs

    Public: Oct 19, 2026, 6:10 PM EDTOriginal source ↗
  2. ARQTLobbying report·Lobbying disclosures

    ARQT: third_quarter 2026 lobbying report

    Issues related to tariffs

    Public: Sep 17, 2026, 3:53 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.